Clinical Trial Update: An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption [Phase 2]

View source ↗

Summary

Phase 2 trial assessing effectiveness, safety, and palatability of pancrelipase microtablets in infants and toddlers with cystic fibrosis and fat malabsorption …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Pancrelipase microtablets (pancrelipase)

Snippet

Sponsor: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | Conditions: Cystic Fibrosis, Steatorrhea | Phase 2 | Status: COMPLETED